202 related articles for article (PubMed ID: 36572873)
21. Can morphological MRI differentiate between primary central nervous system lymphoma and glioblastoma?
Malikova H; Koubska E; Weichet J; Klener J; Rulseh A; Liscak R; Vojtech Z
Cancer Imaging; 2016 Nov; 16(1):40. PubMed ID: 27894359
[TBL] [Abstract][Full Text] [Related]
22. Whole-brain amide proton transfer (APT) and nuclear overhauser enhancement (NOE) imaging in glioma patients using low-power steady-state pulsed chemical exchange saturation transfer (CEST) imaging at 7T.
Heo HY; Jones CK; Hua J; Yadav N; Agarwal S; Zhou J; van Zijl PC; Pillai JJ
J Magn Reson Imaging; 2016 Jul; 44(1):41-50. PubMed ID: 26663561
[TBL] [Abstract][Full Text] [Related]
23. Differentiating between Primary Central Nervous System Lymphoma and Glioblastoma: The Diagnostic Value of Combining
Hatakeyama J; Ono T; Takahashi M; Oda M; Shimizu H
Neurol Med Chir (Tokyo); 2021 Jun; 61(6):367-375. PubMed ID: 33967177
[TBL] [Abstract][Full Text] [Related]
24. MR imaging based fractal analysis for differentiating primary CNS lymphoma and glioblastoma.
Liu S; Fan X; Zhang C; Wang Z; Li S; Wang Y; Qiu X; Jiang T
Eur Radiol; 2019 Mar; 29(3):1348-1354. PubMed ID: 30167811
[TBL] [Abstract][Full Text] [Related]
25. Differentiation of Malignant and Benign Head and Neck Tumors with Amide Proton Transfer-Weighted MR Imaging.
Yu L; Li C; Luo X; Zhou J; Zhang C; Zhang Y; Chen M
Mol Imaging Biol; 2019 Apr; 21(2):348-355. PubMed ID: 29987616
[TBL] [Abstract][Full Text] [Related]
26. [Preliminary application of amide proton transfer imaging signal in acute ischemic stroke].
Luo XJ; Chen M; Zhang C; Song GD; Li CM; Gong T; Zhou JY
Zhonghua Yi Xue Za Zhi; 2016 Aug; 96(29):2336-41. PubMed ID: 27524192
[TBL] [Abstract][Full Text] [Related]
27. Reproducibility of APT-weighted CEST-MRI at 3T in healthy brain and tumor across sessions and scanners.
Wu Y; Wood TC; Derks SHAE; Pruis IJ; van der Voort S; van Zanten SEMV; Smits M; Warnert EAH
Sci Rep; 2023 Oct; 13(1):18115. PubMed ID: 37872418
[TBL] [Abstract][Full Text] [Related]
28. Juxtacortical susceptibility changes in progressive multifocal leukoencephalopathy at the gray-white matter junction correlates with iron-enriched macrophages.
Mahajan KR; Amin M; Poturalski M; Lee J; Herman D; Zheng Y; Androjna C; Howell M; Fox RJ; Trapp BD; Jones SE; Nakamura K; Ontaneda D
Mult Scler; 2021 Dec; 27(14):2159-2169. PubMed ID: 33749379
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of amide proton transfer imaging for bladder cancer histopathologic features: A comparative study with diffusion- weighted imaging.
Wang F; Xiang YS; Wu P; Shen AJ; Wang PJ
Eur J Radiol; 2023 Feb; 159():110664. PubMed ID: 36574743
[TBL] [Abstract][Full Text] [Related]
30. Amide proton transfer imaging for differentiation of tuberculomas from high-grade gliomas: Preliminary experience.
Kulanthaivelu K; Jabeen S; Saini J; Raju S; Nalini A; Sadashiva N; Hegde S; Rolla NK; Saha I; M N; Vengalil S; Swaroop S; Rao S
Neuroradiol J; 2021 Oct; 34(5):440-448. PubMed ID: 33823712
[TBL] [Abstract][Full Text] [Related]
31. Primary central nervous system lymphoma and glioblastoma differentiation based on conventional magnetic resonance imaging by high-throughput SIFT features.
Chen Y; Li Z; Wu G; Yu J; Wang Y; Lv X; Ju X; Chen Z
Int J Neurosci; 2018 Jul; 128(7):608-618. PubMed ID: 29183170
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of Brain Tumors Using Amide Proton Transfer Imaging: A Comparison of Normal Amide Proton Transfer Signal With Abnormal Amide Proton Transfer Signal Value.
Sugawara K; Miyati T; Wakabayashi H; Yoshimaru D; Komatsu S; Hagiwara K; Saigusa K; Ohno N
J Comput Assist Tomogr; 2023 Jan-Feb 01; 47(1):121-128. PubMed ID: 36112043
[TBL] [Abstract][Full Text] [Related]
33. Added value of amide proton transfer imaging to conventional and perfusion MR imaging for evaluating the treatment response of newly diagnosed glioblastoma.
Park KJ; Kim HS; Park JE; Shim WH; Kim SJ; Smith SA
Eur Radiol; 2016 Dec; 26(12):4390-4403. PubMed ID: 26883333
[TBL] [Abstract][Full Text] [Related]
34. Does adding FDG-PET to MRI improve the differentiation between primary cerebral lymphoma and glioblastoma? Observer performance study.
Makino K; Hirai T; Nakamura H; Murakami R; Kitajima M; Shigematsu Y; Nakashima R; Shiraishi S; Uetani H; Iwashita K; Akter M; Yamashita Y; Kuratsu J
Ann Nucl Med; 2011 Jul; 25(6):432-8. PubMed ID: 21404136
[TBL] [Abstract][Full Text] [Related]
35. Relaxation-compensated amide proton transfer (APT) MRI signal intensity is associated with survival and progression in high-grade glioma patients.
Paech D; Dreher C; Regnery S; Meissner JE; Goerke S; Windschuh J; Oberhollenzer J; Schultheiss M; Deike-Hofmann K; Bickelhaupt S; Radbruch A; Zaiss M; Unterberg A; Wick W; Bendszus M; Bachert P; Ladd ME; Schlemmer HP
Eur Radiol; 2019 Sep; 29(9):4957-4967. PubMed ID: 30809720
[TBL] [Abstract][Full Text] [Related]
36. Association of Progressive Multifocal Leukoencephalopathy Lesion Volume With JC Virus Polymerase Chain Reaction Results in Cerebrospinal Fluid of Natalizumab-Treated Patients With Multiple Sclerosis.
Wijburg MT; Kleerekooper I; Lissenberg-Witte BI; de Vos M; Warnke C; Uitdehaag BMJ; Barkhof F; Killestein J; Wattjes MP
JAMA Neurol; 2018 Jul; 75(7):827-833. PubMed ID: 29532061
[TBL] [Abstract][Full Text] [Related]
37. The pH sensitivity of APT-CEST using phosphorus spectroscopy as a reference method.
Schüre JR; Shrestha M; Breuer S; Deichmann R; Hattingen E; Wagner M; Pilatus U
NMR Biomed; 2019 Nov; 32(11):e4125. PubMed ID: 31322308
[TBL] [Abstract][Full Text] [Related]
38. Radiomics features to distinguish glioblastoma from primary central nervous system lymphoma on multi-parametric MRI.
Kim Y; Cho HH; Kim ST; Park H; Nam D; Kong DS
Neuroradiology; 2018 Dec; 60(12):1297-1305. PubMed ID: 30232517
[TBL] [Abstract][Full Text] [Related]
39. Amide proton transfer imaging to predict tumor response to neoadjuvant chemotherapy in locally advanced rectal cancer.
Nishie A; Asayama Y; Ishigami K; Ushijima Y; Takayama Y; Okamoto D; Fujita N; Tsurumaru D; Togao O; Sagiyama K; Manabe T; Oki E; Kubo Y; Hida T; Hirahashi-Fujiwara M; Keupp J; Honda H
J Gastroenterol Hepatol; 2019 Jan; 34(1):140-146. PubMed ID: 29900583
[TBL] [Abstract][Full Text] [Related]
40. Multiparametric analysis from dynamic susceptibility contrast-enhanced perfusion MRI to evaluate malignant brain tumors.
Abreu VS; Tarrio J; Silva J; Almeida F; Pinto C; Freitas D; Filipe JP
J Neuroimaging; 2024; 34(2):257-266. PubMed ID: 38173078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
